KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Non-Current Debt: 2018-2025

Historic Non-Current Debt for Twist Bioscience (TWST) over the last 3 years, with Sep 2025 value amounting to $15.0 million.

  • Twist Bioscience's Non-Current Debt was N/A to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year change of. This contributed to the annual value of $15.0 million for FY2025, which is N/A change from last year.
  • Per Twist Bioscience's latest filing, its Non-Current Debt stood at $15.0 million for Q3 2025, which was down 0.00% from $15.0 million recorded in Q2 2025.
  • Twist Bioscience's Non-Current Debt's 5-year high stood at $15.0 million during Q4 2024, with a 5-year trough of $15.0 million in Q4 2024.
  • In the last 2 years, Twist Bioscience's Non-Current Debt had a median value of $15.0 million in 2025 and averaged $15.0 million.